Trump Administration's Tylenol Autism Claim Sparks Medical Community Pushback Across US

The Trump administration, led by President Donald Trump and Health and Human Services Secretary Robert F. Kennedy Jr., has cautioned pregnant women against using acetaminophen (Tylenol), citing a potential link to an increased risk of autism in children. This stance has faced pushback from medical professionals, including Republican senators who are doctors, and various health experts who emphasize that current scientific evidence does not support a broad ban on Tylenol during pregnancy. Experts recommend that pregnant women use acetaminophen only at the lowest effective dose and for the shortest duration, aligning with guidance from professional organizations like the American College of Obstetricians and Gynecologists. Some practitioners highlight that the studies referenced focus on long-term use exceeding four weeks, and caution that many factors contribute to autism risk beyond medication use. The conflicting messages have caused confusion among pregnant women, with health providers encouraging patients to consult their doctors and rely on established scientific research rather than political statements. Overall, medical communities advocate for informed decision-making based on evidence and personalized healthcare advice rather than generalized warnings.